Education and Training
- M.D., The University of Chicago, 1973
Lesurf, R., O. L. Griffith, M. Griffith, J. Hundal, L. Trani, M. A. Watson, R. Aft, et al. “Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial.” Ann Oncol 28, no. 5 (May 1, 2017): 1070–77. https://doi.org/10.1093/annonc/mdx048.
Ellis, Matthew J., Vera J. Suman, Jeremy Hoog, Rodrigo Goncalves, Souzan Sanati, Chad J. Creighton, Katherine DeSchryver, et al. “Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).” J Clin Oncol 35, no. 10 (April 1, 2017): 1061–69. https://doi.org/10.1200/JCO.2016.69.4406.
McDonald, Sandra A., Elaine R. Mardis, David Ota, Mark A. Watson, John D. Pfeifer, and Jonathan M. Green. “Comprehensive genomic studies: emerging regulatory, strategic, and quality assurance challenges for biorepositories.” Am J Clin Pathol 138, no. 1 (July 2012): 31–41. https://doi.org/10.1309/AJCPXBA69LNSCVMH.
McCarter, Martin D., Cristina R. Antonescu, Karla V. Ballman, Robert G. Maki, Peter W. T. Pisters, George D. Demetri, Charles D. Blanke, et al. “Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence.” J Am Coll Surg 215, no. 1 (July 2012): 53–59. https://doi.org/10.1016/j.jamcollsurg.2012.05.008.
Ellis, Matthew James, Li Ding, Dong Shen, Jingqin Luo, Vera J. Suman, Reece J. Goiffon, John W. Wallis, et al. “Whole genome sequencing to characterize luminal-type breast cancer.” In Journal of Clinical Oncology, Vol. 30. AMER SOC CLINICAL ONCOLOGY, 2012.
Diehl, Kathleen M., Erin M. Green, Armin Weinberg, Wayne A. Frederick, Dennis R. Holmes, Bettye Green, Arden Morris, et al. “Features associated with successful recruitment of diverse patients onto cancer clinical trials: report from the American College of Surgeons Oncology Group.” Ann Surg Oncol 18, no. 13 (December 2011): 3544–50. https://doi.org/10.1245/s10434-011-1818-9.
Chan, E., Q. Shi, J. Garcia-Aguilar, B. G. Wolff, C. S. Johnson, B. Sanders, X. Carrero, M. C. Posner, D. M. Ota, and C. R. Thomas. “Chemoradiation (CRT) Safety Analysis of ACOSOG Z6041: A Phase II Trial of Neoadjuvant (NEO) CRT followed by Local Excision (LE) in uT2 Rectal Cancer (RC).” In International Journal of Radiation Oncology*Biology*Physics, 78:S53–54. Elsevier BV, 2010. https://doi.org/10.1016/j.ijrobp.2010.07.159.
Ota, David M., Heidi Nelson, and Armando Giuliano. “Node biopsy vs. full lymph node dissection for breast cancer.” Bull Am Coll Surg, October 2010.